» Articles » PMID: 31910894

Frameshift Mutations at the C-terminus of HIST1H1E Result in a Specific DNA Hypomethylation Signature

Abstract

Background: We previously associated HIST1H1E mutations causing Rahman syndrome with a specific genome-wide methylation pattern.

Results: Methylome analysis from peripheral blood samples of six affected subjects led us to identify a specific hypomethylated profile. This "episignature" was enriched for genes involved in neuronal system development and function. A computational classifier yielded full sensitivity and specificity in detecting subjects with Rahman syndrome. Applying this model to a cohort of undiagnosed probands allowed us to reach diagnosis in one subject.

Conclusions: We demonstrate an epigenetic signature in subjects with Rahman syndrome that can be used to reach molecular diagnosis.

Citing Articles

Expanding Upon Genomics in Rare Diseases: Epigenomic Insights.

Tan J, Blake E, Farris J, Klee E Int J Mol Sci. 2025; 26(1.

PMID: 39795993 PMC: 11719497. DOI: 10.3390/ijms26010135.


DNA methylation profiling in Kabuki syndrome: reclassification of germline KMT2D VUS and sensitivity in validating postzygotic mosaicism.

Niceta M, Ciolfi A, Ferilli M, Pedace L, Cappelletti C, Nardini C Eur J Hum Genet. 2024; 32(7):819-826.

PMID: 38528056 PMC: 11220151. DOI: 10.1038/s41431-024-01597-9.


Development of a mouse embryonic stem cell model for investigating the functions of the linker histone H1-4.

Abu Alhaija A, Nisar Lone I, Sekeroglu E, Batur T, Angelov D, Dimitrov S FEBS Open Bio. 2023; 14(2):309-321.

PMID: 38098212 PMC: 10839353. DOI: 10.1002/2211-5463.13750.


Identification of a robust DNA methylation signature for Fanconi anemia.

Pagliara D, Ciolfi A, Pedace L, Haghshenas S, Ferilli M, Levy M Am J Hum Genet. 2023; 110(11):1938-1949.

PMID: 37865086 PMC: 10645556. DOI: 10.1016/j.ajhg.2023.09.014.


A case report of a novel HIST1H1E mutation and a review of the bibliography to evaluate the genotype-phenotype correlations.

Zhao W, Zhang Y, Lv T, He J, Zhu B Mol Genet Genomic Med. 2023; 11(12):e2273.

PMID: 37605493 PMC: 10724515. DOI: 10.1002/mgg3.2273.


References
1.
Aref-Eshghi E, Schenkel L, Lin H, Skinner C, Ainsworth P, Pare G . The defining DNA methylation signature of Kabuki syndrome enables functional assessment of genetic variants of unknown clinical significance. Epigenetics. 2017; 12(11):923-933. PMC: 5788422. DOI: 10.1080/15592294.2017.1381807. View

2.
Aryee M, Jaffe A, Corrada-Bravo H, Ladd-Acosta C, Feinberg A, Hansen K . Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays. Bioinformatics. 2014; 30(10):1363-9. PMC: 4016708. DOI: 10.1093/bioinformatics/btu049. View

3.
Butcher D, Cytrynbaum C, Turinsky A, Siu M, Inbar-Feigenberg M, Mendoza-Londono R . CHARGE and Kabuki Syndromes: Gene-Specific DNA Methylation Signatures Identify Epigenetic Mechanisms Linking These Clinically Overlapping Conditions. Am J Hum Genet. 2017; 100(5):773-788. PMC: 5420353. DOI: 10.1016/j.ajhg.2017.04.004. View

4.
Li D, Yuan H, Ortiz-Gonzalez X, Marsh E, Tian L, McCormick E . GRIN2D Recurrent De Novo Dominant Mutation Causes a Severe Epileptic Encephalopathy Treatable with NMDA Receptor Channel Blockers. Am J Hum Genet. 2016; 99(4):802-816. PMC: 5065652. DOI: 10.1016/j.ajhg.2016.07.013. View

5.
Johansson A, Enroth S, Gyllensten U . Continuous Aging of the Human DNA Methylome Throughout the Human Lifespan. PLoS One. 2013; 8(6):e67378. PMC: 3695075. DOI: 10.1371/journal.pone.0067378. View